封面
市場調查報告書
商品編碼
1629894

全球機械呼吸器市場 - 2025-2033

Global Mechanical Ventilator Market - 2025-2033

出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2023年,全球機械呼吸器市場規模達30.3億美元,預計2033年將達到46.3億美元,2025-2033年預測期間複合年成長率為4.2%。

機械呼吸器是生命維持設備,可幫助或取代無法自主呼吸的患者的自主呼吸。它們將受控氣流輸送到肺部,確保適當的氧合和二氧化碳去除。它們用於 ICU、手術室和急診等重症監護環境,可治療因 ARDS、COPD 或創傷等疾病引起的呼吸衰竭。它們有侵入式和非侵入式兩種型號,提供先進的功能,可根據患者的個人需求量身定做通氣設置,從而改善結果並減少併發症。

市場動態:

驅動程式和限制

呼吸器技術的進步

全球機械呼吸器市場由技術進步推動,包括攜帶式和輕型設計、整合監控系統、無線連接和人工智慧演算法。這些功能可實現個人化的通氣策略並改善患者的治療效果。非侵入性通氣系統減少了侵入性手術的需要,提高了患者的舒適度並降低了風險。這些技術改進不僅擴展了機械呼吸器的組件,還滿足了不同患者群體對高效、方便用戶使用且適應性強的呼吸護理解決方案不斷成長的需求。

例如,2024 年 2 月,Getinge 在印度推出了 Servo-c 機械呼吸機,旨在滿足兒科和成人患者的多樣化呼吸需求。該呼吸器提供肺部保護性治療工具,是印度各地醫院向提供先進且負擔得起的先進醫療保健解決方案邁出的重要一步。隨著醫療保健成本不斷上升,人們越來越注重投資安全、高品質和永續的解決方案。 Getinge 的 Servo-c 借鑒了 50 多年的 Servo 性能,旨在簡化呼吸支援並以合理的價格提供最先進的設備。

呼吸器成本高

全球機械呼吸器市場因成本高而面臨挑戰,特別是在中低收入國家。具有整合監測系統和人工智慧等先進功能的先進呼吸機價格較便宜,限制了小型醫院和家庭護理機構的採用。維護、消耗品和操作員培訓費用也增加了財務負擔。這些因素阻礙了廣泛採用,特別是在醫療預算有限的地區,影響了市場的成長潛力。

例如,高敏銳度呼吸器是醫院重症監護室最受歡迎的呼吸器類型。這些呼吸器具有基於渦輪的供氣和比例電磁氣體輸送系統 (PSOL),用於治療患有嚴重呼吸道疾病或感染的患者。它們的價格在 20,000 美元到 55,000 美元之間,通常用於家庭護理和攜帶式呼吸機。

目錄

第 1 章:方法與範圍

第 2 章:定義與概述

第 3 章:執行摘要

第 4 章:動力學

  • 影響因素
    • 促進要素
      • 呼吸器技術的進步
    • 限制
      • 呼吸器成本高
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第 6 章:依產品類型

  • 重症監護呼吸機
    • 容量控制呼吸機
    • 壓力控制呼吸機
    • 組合模式呼吸機
  • 攜帶式/運輸呼吸機
  • 新生兒呼吸機

第 7 章:按組件

  • 呼吸器
  • 呼吸器配件

第 8 章:依通氣模式分類

  • 侵入性通氣
  • 非侵入性通氣

第 9 章:最終用戶

  • 醫院
  • 門診手術中心
  • 家庭護理設置
  • 緊急情況和交通設置
  • 長期照護中心

第 10 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 11 章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章:公司簡介

  • Medtronic Plc
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Philips Healthcare
  • Hamilton Medical AG
  • GE Healthcare
  • Dragerwerk AG & Co. KGaA
  • Vyaire Medical, Inc.
  • Smith's Medical
  • ResMed Inc.
  • Fisher & Paykel Healthcare Corporation Limited
  • Allied Healthcare Products, Inc.

第 13 章:附錄

簡介目錄
Product Code: MD880

The global Mechanical Ventilator market reached US$ 3.03 billion in 2023 and is expected to reach US$ 4.63 billion by 2033, growing at a CAGR of 4.2% during the forecast period 2025-2033.

Mechanical ventilators are life-support devices that assist or replace spontaneous breathing in patients who cannot breathe on their own. They deliver controlled airflow into the lungs, ensuring proper oxygenation and carbon dioxide removal. Used in critical care settings like ICUs, operating rooms, and emergency departments, they manage respiratory failure caused by conditions like ARDS, COPD, or trauma. Available in invasive and non-invasive models, they offer advanced features to tailor ventilation settings to individual patient needs, improving outcomes and reducing complications.

Market Dynamics: Drivers & Restraints

Advancements in Ventilator Technology

The global mechanical ventilator market is driven by technological advancements, including portable and lightweight designs, integrated monitoring systems, wireless connectivity, and artificial intelligence algorithms. These features enable personalized ventilation strategies and improved patient outcomes. Non-invasive ventilation systems reduce the need for invasive procedures, enhancing patient comfort and reducing risks. These technological improvements not only expand the Components of mechanical ventilators but also meet the growing demand for efficient, user-friendly, and adaptable respiratory care solutions across diverse patient populations.

For instance, in February 2024, Getinge has launched its Servo-c mechanical ventilator in India, designed to address the diverse respiratory needs of pediatric and adult patients. The ventilator offers lung-protective therapeutic tools and is a significant step towards making advanced healthcare solutions accessible and affordable for hospitals across India. With rising healthcare costs, there is an increased focus on investing in safe, high-quality, and sustainable solutions. Getinge's Servo-c, drawing from over 50 years of Servo performance, aims to simplify respiratory support and provide access to state-of-the-art equipment at a reasonable price.

High Cost of Ventilators

The global mechanical ventilator market faces challenges due to high costs, particularly in low- and middle-income countries. Advanced ventilators with advanced features like integrated monitoring systems and artificial intelligence are less affordable, limiting adoption in smaller hospitals and homecare settings. Maintenance, consumables, and operator training expenses also add to the financial burden. These factors hinder widespread adoption, especially in regions with limited healthcare budgets, affecting the market's growth potential.

For instance, High-acuity ventilators are the most sought-after type of ventilator for intensive care units in hospitals. These ventilators, which have a turbine-based air supply and proportional solenoid gas delivery system (PSOL), are used to treat patients with severe respiratory illnesses or infections. They can cost between $20,000 and $55,000 and are commonly used in home care and portable ventilators.

Segment Analysis

The global mechanical ventilator market is segmented based on product type, component, mode of ventilation, end user and region.

Product Type:

Critical Care Ventilators segment is expected to dominate the Mechanical Ventilator market share

The critical care ventilators segment holds a major portion of the mechanical ventilator market share and is expected to continue to hold a significant portion of the mechanical ventilator market share during the forecast period.

Critical care ventilators are essential in managing severe respiratory conditions in intensive care units (ICUs). They provide precise and reliable support for patients with ARDS, COPD, and other critical conditions. Their customizable ventilation modes, real-time monitoring, and integration with hospital systems make them a preferred choice for healthcare professionals. The rising prevalence of life-threatening respiratory disorders and the increasing number of ICU admissions have fueled demand for critical care ventilators, making them a cornerstone of the mechanical ventilator market.

For instance, in July 2024, Air Liquide Medical Systems has introduced the Monnal TEO, a French ventilator designed for intensive care and critical care services. The ventilator, manufactured in France, was developed in collaboration with the Angers University Hospital's intensive care unit, aiming to improve ventilatory care for patients with acute respiratory failure. The company continues to be a pioneer in mechanical ventilation.

End User:

Hospitals segment is the fastest-growing segment in Mechanical Ventilator market share

The hospitals segment is the fastest-growing segment in the mechanical ventilator market share and is expected to hold the market share over the forecast period.

Hospitals are the primary users of mechanical ventilators, as they require advanced respiratory care solutions for critically ill patients. The increasing prevalence of respiratory diseases, ICU admissions, and surgeries requiring post-operative ventilation support have boosted the adoption of ventilators in hospitals. Investments in healthcare infrastructure and government initiatives to equip hospitals with advanced medical devices are driving market growth. Hospitals' reliance on ventilators for emergency and long-term care solidifies their central role in shaping the mechanical ventilator market landscape.

For instance, according to Society of Critical Care Medicine Over 5 million patients are admitted to U.S. ICUs annually for monitoring, support, stabilization, management, and comfort. Although diverse, all ICU patients require frequent assessments, clinical expertise, and technological support. They require more clinical expertise than non-ICU patients, requiring a greater focus on comfort and care.

Geographical Analysis

North America is expected to hold a significant position in the Mechanical Ventilator market share

North America holds a substantial position in the mechanical ventilator market and is expected to hold most of the market share due to its advanced healthcare infrastructure, high prevalence of respiratory diseases, FDA clearance and significant healthcare expenditures. The US is particularly significant due to the increasing demand for ventilators due to chronic respiratory conditions like COPD, asthma, and sleep apnea. The aging population and a strong healthcare system contribute to the demand for advanced respiratory care solutions.

For instance, in November 2024, CorVent Medical has received FDA 510(k) clearance for its RESPOND ventilator, a cost-effective, smart ventilation system designed to provide quality care for healthcare systems, providers, and patients. The ventilator is a lightweight, easy-to-use system that combines traditional mechanical ventilation with durable components, eliminating the need for service and maintenance contracts. It comes with a 5-year Limited Warranty, making the total cost of ownership the purchase price. The RESPOND ventilator uses non-proprietary circuits and accessories for long-term affordability.

Moreover, in October 2024, Nihon Kohden America, a global medical technology leader, has introduced the NKV-440 Ventilator System, previously available through OrangeMed, to a wider range of healthcare providers.

Furthermore, government initiatives, such as substantial funding for hospitals and strategic stockpiling of medical equipment, further support the market's growth. North American hospitals invest heavily in ventilator technologies, including high-end critical care ventilators with customizable settings, real-time monitoring, and artificial intelligence-driven decision support.

Europe is growing at the fastest pace in the Mechanical Ventilator market

Europe holds the fastest pace in the mechanical ventilator market and is expected to hold most of the market share due to the aging population, increasing respiratory disorders, and advancements in medical technologies. The region's elderly population, particularly those with chronic respiratory diseases like COPD, pneumonia, and asthma, has a high demand for ventilators in both hospitals and homecare settings. The COVID-19 pandemic accelerated this demand, leading to rapid advancements in ventilator production and government policies to increase availability. Countries like Italy, Germany, and the UK expanded their healthcare budgets to ensure hospitals were well-equipped to handle respiratory crises.

For instance, in November 2024, The British Thoracic Society (BTS) has released its Model of Care for Complex Home Mechanical Ventilation (HMV), aiming to establish standards of care and provide guidance on infrastructure and resourcing for ventilatory failure patients in the UK. HMV is used to support patients with respiratory, neuromuscular, and chest wall disorders, and is beneficial for conditions like Chronic Obstructive Pulmonary Disease, Obesity-Related Respiratory Failure, Motor Neurone Disease, and Duchenne Muscular Dystrophy.

Competitive Landscape

The major global players in the mechanical ventilator market include Medtronic plc, Philips Healthcare, Hamilton Medical AG, GE Healthcare, Dragerwerk AG & Co. KGaA, Vyaire Medical, Inc., Smiths Medical, ResMed Inc, Fisher & Paykel Healthcare Corporation Limited, Allied Healthcare Products, Inc and among others.

Key Developments

  • In September 2024, Inspira Technologies, a medical technology company, has secured an additional U.S. patent for the VORTX orbiting blood oxygenation delivery system, a core technology of the INSPIRA ART device. This brings the total number of claims deemed novel related to the INSPIRA ART device to 32.
  • In October 2024, Nihon Kohden America has expanded the availability of its NKV-440 Ventilator System to a wider range of healthcare providers, enhancing respiratory support and helping overcome challenges like staff shortages and budget limitations.

Emerging Players

The emerging players in the mechanical ventilator market include AgVa Healthcare, Fritz Stephan GmbH, Dima Italia and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global mechanical ventilator market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Component
  • 3.3. Snippet by Mode of Ventilation
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Advancements in Ventilator Technology
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Ventilators
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Critical Care Ventilators*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Volume-Controlled Ventilators
    • 6.2.4. Pressure-Controlled Ventilators
    • 6.2.5. Combined Mode Ventilators
  • 6.3. Portable/Transport Ventilators
  • 6.4. Neonatal Ventilators

7. By Component

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 7.1.2. Market Attractiveness Index, By Component
  • 7.2. Ventilator Machines*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ventilator Accessories

8. By Mode of Ventilation

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Ventilation
    • 8.1.2. Market Attractiveness Index, By Mode of Ventilation
  • 8.2. Invasive Ventilation*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Non-Invasive Ventilation

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgery Centers
  • 9.4. Home Care Settings
  • 9.5. Emergency and Transport Settings
  • 9.6. Long-Term Care Centers

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Ventilation
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Ventilation
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Ventilation
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Ventilation
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Ventilation
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Medtronic Plc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Philips Healthcare
  • 12.3. Hamilton Medical AG
  • 12.4. GE Healthcare
  • 12.5. Dragerwerk AG & Co. KGaA
  • 12.6. Vyaire Medical, Inc.
  • 12.7. Smith's Medical
  • 12.8. ResMed Inc.
  • 12.9. Fisher & Paykel Healthcare Corporation Limited
  • 12.10. Allied Healthcare Products, Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us